BioSpace News Archive

Epic Bio has presented new data demonstrating the achievement of persistent gene activation using its Gene Expression Modulation System (GEMS) platform.

Berkshire Biomedical Corporation announced today that John Timberlake , Chief Executive Officer, will present at the fourth annual Life Science Intelligence (LSI) USA ’23 Emerging Medtech Summit on March 22, 2023.

Castle Biosciences, Inc. today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum on Wednesday, March 22, 2023, at 2:15 p.m. Eastern time.

The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. today announced that the first patient has been enrolled in an FDA-approved clinical trial evaluating Nantheia™ ATL5 , an investigational drug using cannabidiol in ANANDA’s proprietary Liquid Structure™ delivery technology, for Post-Traumatic Stress Disorder (PTSD).

DEM BioPharma, Inc. today announced the addition of Miriam Merad, M.D., Ph.D., to its Scientific Advisory Board.

Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they have signed a long-term strategic partnership continuing their long-standing relationship and marking ambitions to advance radiology and cardiology patient care.

Medivir AB announced that the first patient with hepatocellular carcinoma has started treatment in phase 2a with the candidate drug fostroxacitabine bralpamide in combination with Lenvima®.

ADAMA Ltd., a leading crop protection company, announced that it has exercised its call option to acquire the remaining 40% stake in ADAMA Chile, formerly known as Chile Agro.

Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced it has shipped the first enzymatically synthesized oligonucleotides to top biotechnology, academic, and synthetic biology researchers, delivered as part of a key customer program.

Henry Schein, Inc. announced that it will showcase its comprehensive solutions and provide its perspective on the future of dentistry at the 2023 International Dental Show in Cologne, Germany.